Evidence of polyclonal hematopoiesis in a large proportion of patients with low-risk myelodysplastic syndrome.

被引:0
作者
Malcovati, L
Della Porta, MG
Galli, A
Boggi, S
Malabarba, L
Pietra, D
Passamonti, F
Bergamaschi, G
Lazzarino, M
Cazzola, M
机构
[1] Univ Pavia, Div Hematol, Sch Med, I-27100 Pavia, Italy
[2] Policlin San Matteo, IRCCS, I-27100 Pavia, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2364
引用
收藏
页码:649A / 650A
页数:2
相关论文
共 50 条
[41]   Quality of Life in Low-Risk Myelodysplastic Syndrome: A Cross-Sectional Study [J].
Kaygusuz-Atagunduz, Isik ;
Ozen, Mirac ;
Firatli-Tuglular, Tulin ;
Toptas, Tayfur .
BLOOD, 2015, 126 (23)
[42]   A phase 2, single-arm, open-label trial to evaluate the effectiveness of darbepoetin alfa for the treatment of anemia in patients with low-risk myelodysplastic syndrome. [J].
Gabrilove, J ;
Paquette, R ;
Lyons, R ;
Mushtaq, C ;
Sekeres, M ;
Lam, H ;
Dreiling, L .
BLOOD, 2005, 106 (11) :714A-714A
[43]   Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes [J].
Ma, Xiaomei ;
Wang, Rong ;
Galili, Naomi ;
Mayne, Susan T. ;
Wang, Sa A. ;
Yu, Herbert ;
Raza, Azra .
CANCER CAUSES & CONTROL, 2011, 22 (04) :623-629
[44]   Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes [J].
Xiaomei Ma ;
Rong Wang ;
Naomi Galili ;
Susan T. Mayne ;
Sa A. Wang ;
Herbert Yu ;
Azra Raza .
Cancer Causes & Control, 2011, 22 :623-629
[45]   Supportive therapy for low-risk myelodysplastic syndromes [J].
Gay, Julie .
HEMATOLOGIE, 2008, 14 (03) :178-184
[46]   rHuEpo treatment in low-risk myelodysplastic syndromes [J].
Grossi, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (02) :574-574
[47]   Amifostine in the treatment of low-risk myelodysplastic syndromes [J].
Grossi, A ;
Fabbri, A ;
Santini, V ;
Leoni, F ;
Nozzoli, C ;
Longo, G ;
Pagliai, G ;
Ciolli, S ;
Ferrini, PR .
HAEMATOLOGICA, 2000, 85 (04) :367-371
[48]   Erythropoietin for the anemia of low-risk myelodysplastic syndromes [J].
Fenaux, P ;
Ades, L .
BLOOD, 2005, 106 (03) :768-769
[49]   Low-risk myelodysplastic syndromes and iron overload [J].
Fenaux, Pierre .
HEMATOLOGIE, 2006, 12 :9-9
[50]   Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome [J].
M. A. Aloe Spiriti ;
R. Latagliata ;
P. Niscola ;
A. Cortelezzi ;
M. Francesconi ;
D. Ferrari ;
E. Volpe ;
M. Clavio ;
A. Grossi ;
M. Tambone Reyes ;
P. Musto ;
M. E. Mitra ;
A. Azzarà ;
D. Pagnini ;
G. D’Arena ;
A. Spadano ;
E. Balleari ;
P. Pecorari ;
E. Capochiani ;
E. De Biasi ;
D. Perego ;
B. Monarca ;
F. Pisani ;
G. Scaramella ;
M. C. Petti .
Annals of Hematology, 2005, 84 :167-176